Being diagnosed with herpes can lead to a range of emotions, along with important questions about what it means for your health. One concern that often comes up is whether having herpes increases the risk of other sexually transmitted infections, or whether those infections might already be present without obvious signs.
That concern is valid. Studies have found that people with genital herpes, particularly HSV-2, are more likely to also have infections like HIV, syphilis, gonorrhea, or chlamydia. In one study from Saudi Arabia, researchers noted high co-infection rates among herpes-positive patients. A study in South Africa found that 60 percent of women with HSV-2 were also HIV-positive. Similar patterns have been seen in other countries, including Chile, where HSV-2 infection was closely linked to HIV positivity.
Understanding these links matters. Herpes can make the body more vulnerable to other infections. Breaks in the skin, changes in immune response, and the fact that herpes can be transmitted even without symptoms all play a role. This makes testing, early detection, and clear communication especially important.
This article explores the connections between herpes and other STIs, why co-infections occur, and how to take steps toward prevention and care. The goal is to offer reliable information without judgment, and to support you in making informed decisions about your health.
Herpes and the Broader STI Landscape
Herpes is often talked about on its own, but it’s important to understand how it fits into the larger picture of sexual health. Both HSV-1 and HSV-2 are viral infections that stay in the body permanently. After the initial infection, the virus settles into nerve pathways, where it can become active again from time to time. These reactivations may cause visible sores, but often there are no symptoms at all.
Because of this, many people carry herpes without knowing it. The virus can be passed on even when no sores are present, which is one reason it’s so common. Herpes spreads through direct skin or mucosal contact, not just through sexual fluids. This means it can be transmitted during oral, vaginal, or anal sex, and even through close skin contact in some cases. Its ability to spread silently makes it different from many other STIs and contributes to its role in broader transmission patterns.
What’s especially important to understand is that while herpes itself doesn’t cause other STIs, having herpes can increase the risk of getting one. The virus can cause tiny breaks in the skin or mucous membranes, which create easy entry points for other infections. It can also trigger an immune response in the area, drawing in immune cells that some viruses, like HIV, use to establish infection. This biological interaction helps explain why herpes and HIV often appear together in research studies. For example, people with HSV-2 are several times more likely to acquire HIV, and having herpes can increase the chance of passing HIV to a partner.
This risk is not limited to HIV. Other STIs like syphilis or gonorrhea may also find it easier to take hold when the skin is already irritated or healing from a herpes outbreak. On the flip side, someone who already has another STI may be more vulnerable to catching herpes too.
Looking at herpes in the context of other STIs helps explain why testing and communication are so important. No single infection exists in a vacuum. The more we understand how they overlap, the better we can protect our health and support the health of others.
Herpes and HIV: The Strongest Link
Among all the connections between herpes and other sexually transmitted infections, the link to HIV is the most well established. Having HSV-2 can significantly increase a person’s risk of both acquiring and passing on HIV. This is not just a matter of shared risk factors, but also of how the two viruses interact in the body.
When HSV-2 causes genital sores or even microscopic tears in the skin, it creates openings that HIV can easily pass through. Even when no sores are visible, the herpes virus can still be active, and the immune system may be responding in ways that make infection more likely. For example, herpes attracts immune cells to the surface of the skin—some of the same cells that HIV targets to spread. Studies show that HSV-2 can triple the chances of acquiring HIV through these pathways.
For people already living with HIV, herpes can add another layer of complication. When HSV-2 reactivates, it can raise the level of HIV in the genital area and in the bloodstream. This makes it easier to transmit HIV to others, even if the person is taking antiretroviral medications. In this way, herpes doesn’t just raise the risk of getting HIV. It can also affect how easily HIV spreads.
Managing both viruses together requires a proactive approach. Suppressive therapy with daily antiviral medication can reduce herpes outbreaks and lower HIV levels in the body. Using condoms consistently adds another layer of protection, especially for couples where only one partner is HIV-positive. Research supports combining these strategies—condoms, medication, and regular testing—as the most effective way to protect both partners and reduce the risk of transmission.
This kind of care takes planning, but it’s entirely possible. Many people manage both conditions with the support of healthcare providers and thoughtful routines. The key is understanding how these viruses interact and staying committed to tools that keep everyone safer.
Herpes and HPV: Different Viruses, Overlapping Risks
Herpes and HPV are both common viral infections, and while they are very different in how they behave in the body, they share some important similarities. Both are primarily spread through direct skin or mucosal contact during sexual activity. This means they do not rely on the exchange of fluids the way some other STIs do, which makes them easier to pass along even when no symptoms are present.
One of the reasons these infections spread so easily is that they can enter through tiny tears or microabrasions in the skin. These small openings often happen during sex and are usually invisible. Since condoms do not cover all areas that can shed either virus, they lower the risk but do not eliminate it completely.
Genital herpes and HPV can also exist in the body for years without being detected. Many people who have one may also have the other without knowing it. Both viruses are able to hide from the immune system, becoming inactive for stretches of time and then returning. During those silent periods, transmission is still possible.
Even though herpes and HPV can coexist, they have very different long-term effects. HPV, especially high-risk strains, is known to cause cancers of the cervix, anus, and throat, among others. Herpes, in contrast, is not linked to cancer. It can cause painful and recurring sores, but it does not carry the same oncogenic risk.
This makes routine care especially important. Pap smears are a key tool for detecting early signs of cervical changes caused by HPV, even in people who feel completely healthy. The HPV vaccine offers strong protection, especially when given before someone becomes sexually active. And for everyone, open communication with partners and healthcare providers helps support both prevention and peace of mind.
Herpes and HPV are different in many ways, but understanding where their risks overlap can help you make informed decisions about your sexual health.
Herpes and Bacterial STIs (Chlamydia, Gonorrhea, Syphilis)
Herpes is a viral infection, but it doesn’t exist in isolation. When it comes to bacterial STIs like chlamydia, gonorrhea, and syphilis, herpes can play a role in increasing both the risk of infection and the severity of symptoms. This connection often comes down to how herpes affects the skin and immune system.
During an outbreak, herpes causes open sores or microscopic breaks in the genital area. These disruptions to the skin and mucosal lining make it easier for bacteria to enter the body. At the same time, the immune response that herpes activates can draw in the very cells that bacterial infections target. This makes someone with an active herpes outbreak more susceptible to contracting another STI.
But the relationship can work both ways. If someone already has a bacterial STI, it may worsen their herpes symptoms. For example, co-infection with syphilis has been linked to deeper and more painful ulcers. Gonorrhea and chlamydia can trigger inflammation that may prolong herpes outbreaks or increase how much virus is shed, even when no sores are visible.
Because these infections often overlap, it’s important not to assume that one diagnosis explains everything. A person diagnosed with herpes might also have another STI that hasn’t yet been detected. Studies have shown that people with genital ulcers are frequently co-infected, sometimes with multiple bacteria at once.
This is why comprehensive testing matters. Routine panels should include checks for bacterial STIs alongside herpes, especially for anyone experiencing symptoms or who has recently had a new sexual partner. Testing is not just about identifying what’s present—it’s also a key step in stopping transmission, starting treatment early, and protecting long-term health.
Taking herpes seriously includes looking at the broader picture. Being thorough with testing and honest with providers can help ensure that nothing gets missed.
Why Co-Infections Are Often Missed
One of the biggest challenges in sexual health is that many STIs, including herpes, often come without symptoms. This silence allows infections to go unnoticed and untreated, especially when routine testing is not part of someone’s healthcare plan. Research shows that a high number of people with HSV-2, as well as other infections like chlamydia, trichomoniasis, and gonorrhea, have no clear signs that anything is wrong.
Because herpes can be so subtle, it’s easy to assume that any irritation or unusual sensation is caused by herpes alone. But other infections can produce similar symptoms. Discharge, itching, and burning during urination are not unique to herpes. Without testing, these symptoms may be misread or dismissed, and co-infections can be missed entirely.
This issue is common. Studies have found that people diagnosed with herpes sometimes also have HIV or syphilis without realizing it. In many cases, people carry HSV antibodies without ever recalling an outbreak. These silent infections continue to be spread because people simply do not know they are there.
There is also a gap in how testing is often handled. Herpes is not routinely included in standard STI panels unless someone specifically asks for it. This means that even people who believe they have been fully tested may still be unaware of their herpes status. It also means that some may feel falsely reassured when their results come back negative, not realizing the test was incomplete.
The best way to uncover hidden infections is through comprehensive screening. This often includes both blood tests and swabs, depending on symptoms and risk factors. Regular, full-panel testing helps create a clearer picture of sexual health. When people understand that symptoms alone are not a reliable guide, they can take steps to protect themselves and others.
The Role of Regular Testing and Communication
Regular testing is one of the most effective ways to take charge of your sexual health. It helps identify infections early, supports timely treatment, and lowers the chances of passing something on to others. This is especially important after new sexual partners, even when no symptoms are present. Many STIs, including herpes, are often silent in the body, which means you can’t rely on how you feel to know if you’re healthy.
Studies have shown that even people who report consistent safe sex practices can still test positive for infections like chlamydia, syphilis, or gonorrhea. These findings are not limited to any one group but are especially common in communities where access to testing or education has been limited by stigma or systemic barriers. For people already living with herpes, testing for other STIs remains important. Co-infections can happen without obvious symptoms, and regular screening helps catch them early.
When speaking with a healthcare provider, it’s important to ask about comprehensive STI panels. Many standard screenings do not include herpes unless it’s specifically requested. This is also true for other tests, like hepatitis or syphilis, which may not be part of a basic panel. Blood and swab tests offer a fuller picture and can be adapted to your personal risk factors or symptoms.
For those who feel nervous or unsure about testing, it can help to reframe it as a form of self-care. Getting tested isn’t about judgment—it’s about staying informed and healthy. It also builds trust with partners and providers, and can lead to better outcomes for everyone involved. Some clinics now offer self-testing kits or peer-led education programs, which make the process more comfortable and accessible.
Open communication is another key part of this process. Whether it’s talking to a partner about getting tested together or checking in with your doctor about which tests are appropriate, these conversations matter. They help shift sexual health from something hidden or uncomfortable to something that’s simply part of taking care of yourself.
Managing Co-Infections and Protecting Partners
When it comes to managing STIs, there’s a clear distinction between bacterial and viral infections. Bacterial STIs like chlamydia, gonorrhea, and syphilis are typically curable with antibiotics. Once treated, the infection is usually cleared from the body. Herpes, on the other hand, is a lifelong condition. Caused by HSV-1 or HSV-2, it remains in the body even after symptoms go away and can return without warning.
Managing herpes means focusing on long-term care. Some people take antiviral medication only during outbreaks, while others use daily suppressive therapy to reduce both the number and severity of episodes. This approach can also lower the chance of passing the virus to a partner. Unlike bacterial infections that are treated and resolved, herpes requires ongoing attention.
This makes protection and prevention especially important in relationships. Antiviral therapy and condom use together offer strong protection. Studies have shown that daily treatment with valacyclovir can reduce the risk of transmitting herpes by nearly half, and even more when it comes to preventing visible symptoms in partners. Condoms also help by blocking the virus from reaching the skin or mucosa during sex. While not perfect, consistent condom use lowers the risk of transmission from men to women by as much as 96 percent, and by about two-thirds in the other direction.
Protecting partners also involves communication. Talking openly about STI testing, treatment plans, and protection strategies can build trust and improve outcomes for both people. Couples who make these topics part of their regular conversations are more likely to feel supported and make safer choices together. This includes discussions about timing, preferences, and what to do in case of an outbreak.
Whether you’re managing herpes alone or alongside another STI, shared decision-making and honest dialogue go a long way. They help reduce stigma, strengthen relationships, and make it easier to protect everyone involved.
Emotional Impact of Multiple Diagnoses
Receiving a diagnosis of one sexually transmitted infection can be overwhelming. Finding out that you have more than one can bring on a whole new level of emotional weight. It’s not uncommon for people in this situation to feel anxious, ashamed, or even guilty. These feelings are often tied to the stigma that still surrounds STIs, along with a sense of isolation or fear about what others might think.
Research shows that individuals with multiple STI diagnoses often experience greater emotional distress than those with a single infection. Some report higher levels of shame, sadness, or self-blame, especially when the diagnoses come as a surprise. In younger people and those in vulnerable communities, this emotional burden can sometimes prevent them from reaching out for the support or care they need.
It’s important to remember that these reactions are human. But it’s equally important to know that having one or more STIs does not mean you’ve done anything wrong. These infections are extremely common. Many are treatable, and others, like herpes or HIV, can be managed well with ongoing care. With proper treatment, people with STIs can live healthy lives and have fulfilling relationships.
Stigma thrives in silence, but it loses power in the face of information and compassion. The more we treat sexual health as a normal part of overall wellness, the easier it becomes to seek help without shame. Talking to a trusted provider, connecting with support groups, or simply learning more about your diagnosis can ease the emotional weight and help you move forward with confidence.
No one should feel alone because of an STI diagnosis. Support is available, and taking steps to care for your emotional well-being is just as important as managing the physical side of your health.
Staying Informed, Staying Empowered
Navigating a herpes diagnosis alongside concerns about other STIs can feel like a lot to carry, but you are not alone. This article has explored how herpes interacts with other infections, why co-infections can occur, and what steps you can take to protect your health and your relationships. While it’s true that herpes can increase vulnerability to certain STIs, it’s also true that most of these infections are either curable or manageable with the right care.
Understanding the risks and realities of co-infection doesn’t have to be frightening. In fact, it’s a powerful step toward better health. Regular testing, open conversations with partners, and honest dialogue with healthcare providers all help create a sense of control and clarity. The more we normalize these discussions, the easier it becomes to make choices rooted in self-respect and compassion.
If you found this article helpful, consider joining our mailing list. You’ll receive new articles, trusted information, and resources that support your sexual health journey—without judgment, just facts and encouragement.
References
Abbai, N., Govender, S., & Nyirenda, M. (2018). Herpes simplex virus-2 infections in pregnant women from Durban, South Africa: prevalence, risk factors and co-infection with HIV-1. Southern African Journal of Infectious Diseases.
Ağar, E., & Aker, S. (2023). Association of HPV and sexually transmitted infections among patients with genital warts and asymptomatic individuals: a cross-sectional study. European Journal of Gynaecological Oncology.
Aggarwal, A., & Kaur, R. (2004). Seroprevalence of herpes simplex virus-1 and 2 antibodies in STD clinic patients. Indian Journal of Medical Microbiology, 22(4), 244–246.
Aravantinou, M., Mizenina, O., Calenda, G., Kenney, J., Frank, I., Lifson, J., Szpara, M. L., Jing, L., Koelle, D., Teleshova, N., Grasperge, B. F., Blanchard, J., Gettie, A., Martinelli, E., & Derby, N. (2017). Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques. Frontiers in Microbiology, 8.
Baeten, J. M., Strick, L. B., Lucchetti, A., Whittington, W. L., Sanchez, J., Coombs, R. W., Magaret, A., Wald, A., Corey, L., & Celum, C. (2008). Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. The Journal of infectious diseases, 198(12), 1804–1808.
Cain, D., Sauermilch, D., & Starks, T. J. (2023). Client Responses to Communication Skills Training for HIV Prevention. AIDS and Behavior, 1–15.
Cannovo, N., Bianchini, E., Gironacci, L., Garbati, E., Di Prospero, F., Cingolani, M., Scendoni, R., & Fedeli, P. (2024). Sexually Transmitted Infections in Adolescents and Young Adults: A Cross Section of Public Health. International journal of environmental research and public health, 21(4), 501.
Caputo, A., & Marconi, P. (2021). Vaccine Development for Herpes Simplex Viruses: A Commentary of Special Issue Editors. Vaccines, 9(2), 158.
Centers for Disease Control and Prevention. (2022). Sexually transmitted infections treatment guidelines.
Centers for Disease Control and Prevention. (2022). STDs: General Information.
Chen, J. S., Levintow, S. N., Tran, H., et al. (2021). HIV and STI prevalence and testing history among men who have sex with men in Hanoi, Vietnam. International Journal of STD & AIDS, 33, 193–201.
Chen, S. C., Yin, Y., & Chen, X. (2011). Relationship between herpes simplex virus 2 and human immunodeficiency virus 1 infection. International Journal of Dermatology and Venereology.
Chopra, S., Devi, P., & Devi, B. (2013). Herpes simplex virus 2: a boon to develop other sexually transmitted infections. Journal of the Indian Medical Association, 111(4), 236–238.
Corey, L., & Ashley, R. (2004). Prevention of herpes simplex virus type 2 transmission with antiviral therapy. Herpes: The Journal of the IHMF, 11(Suppl 3), 170A-174A.
de-la-Torre, A., Valdés-Camacho, J., López de Mesa, C., et al. (2019). Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infectious Diseases, 19.
Dodd, R. H., Forster, A. S., Marlow, L. A. V., & Waller, J. (2019). Psychosocial impact of human papillomavirus-related head and neck cancer on patients and their partners: A qualitative interview study. European journal of cancer care, 28(2), e12999.
Drake, A. L., John-Stewart, G. C., Wald, A., Mbori-Ngacha, D., Bosire, R., Wamalwa, D., Lohman-Payne, B., Ashley-Morrow, R., Corey, L., & Farquhar, C. (2007). Herpes Simplex Virus Type 2 and Risk of Intrapartum Human Immunodeficiency Virus Transmission. Obstetrics & Gynecology, 109, 403–409.
Edogbanya, H. O., Momoh, S. O., & Sani, U. (2024). Herpes Simplex Virus Type -2 (HSV-2) and HIV Co-infection Dynamics with Optimal Control. International Journal of Development Mathematics (IJDM).
Etiebet, M., Akolo, C., Iwu, E., et al. (2012). High HIV-1 prevalence, risk behaviors and viral loads seen in men who have sex with men enrolled in a community-based comprehensive HIV/AIDS clinic in Nigeria. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59, 29.
Fageeh, W. (2013). Sexually transmitted infections among patients with herpes simplex virus at King Abdulaziz University Hospital. BMC Research Notes, 6, 301.
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (London, England), 20(1), 73–83.
Gravitt, P., & Jamshidi, R. (2005). Diagnosis and management of oncogenic cervical human papillomavirus infection. Infectious Disease Clinics of North America, 19(2), 439–458.
Gross G. (1999). Do we need antivirals for genital herpes simplex virus and human papillomavirus infection?. International journal of antimicrobial agents, 12(1), 1–3.
Hu, Q., Xu, J., Chu, Z., Zhang, J., Yu, Y., Yu, H., Ding, H., Jiang, Y., Geng, W., Wang, N., & Shang, H. (2017). Prevalence and determinants of herpes simplex virus type 2 (HSV-2)/syphilis co-infection and HSV-2 mono-infection among HIV-positive men who have sex with men: a cross-sectional study in Northeast China. Japanese Journal of Infectious Diseases, 70(3), 284–289.
Jackson, L. J., Al-Janabi, H., Roberts, T., & Ross, J. (2021). Exploring young people’s preferences for STI screening in the UK: A qualitative study and discrete choice experiment. Social Science & Medicine, 279, 113945.
James, S. H., & Kimberlin, D. W. (2015). Neonatal herpes simplex virus infection: epidemiology and treatment. Clinics in Perinatology, 42(1), 47-59.
Johnston C. (2022). Diagnosis and Management of Genital Herpes: Key Questions and Review of the Evidence for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(Suppl_2), S134–S143.
Johnston, C., Morrow, R., & Stanberry, L. (2014). Human Herpesviruses: Herpes Simplex Virus Types 1 and 2. In Human Herpesviruses (pp. 829-853).
Koren, M., & Decker, C. F. (2016). Genital herpes. Disease-a-month : DM, 62(8), 287–293.
Kularadhan, V., Gan, J., Chow, E., Fairley, C., & Ong, J. (2022). HIV and STI testing preferences for men who have sex with men in high-income countries: A scoping review. International Journal of Environmental Research and Public Health, 19.
Lafferty, W. E., Downey, L., Celum, C., & Wald, A. (2000). Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. The Journal of infectious diseases, 181(4), 1454–1457.
Lehtinen, M., et al. (2012). Immunogenicity, Efficacy, Effectiveness and Overall Impact of HPV Vaccines. Springer.
Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Newman, L. M., & Gottlieb, S. L. (2017). First estimates of the global and regional incidence of neonatal herpes infection. The Lancet Global Health, 5(3), e300–e309.
Looker, K. J., Magaret, A. S., Turner, K. M., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015). Global estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One, 10(5), e0129883.
Looker, K., Elmes, J., Gottlieb, S., Schiffer, J., Vickerman, P., Turner, K., & Boily, M. (2017). The effect of HSV-2 infection on subsequent HIV acquisition: An updated systematic review and meta-analysis. Sexually Transmitted Infections, 93, A137-A138.
Lowe, S., Mudzviti, T., Mandiriri, A., et al. (2019). Sexually transmitted infections, the silent partner in HIV-infected women in Zimbabwe. Southern African Journal of HIV Medicine, 20.
Löwhagen, G., Berntsson, M., Bonde, E., Tunbäck, P., & Krantz, I. (2005). Acceptance and outcome of herpes simplex virus type 2 antibody testing in patients attending an STD clinic. Acta Dermato-Venereologica, 85(3), 248–252.
MacKinnon, K. R., Grewal, R., Tan, D. H. S., et al. (2021). Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing. BMC Health Services Research, 21.
Magaret, A., Mujugira, A., Hughes, J., Lingappa, J., et al. (2015). Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples. Clinical Infectious Diseases, 62(4), 456–461.
Martinez, M.J., Navarrete, N., Santander, E., Garmendia, M., & Gubelin, W. (2005). Seroprevalence of herpes simplex virus type 2 (HSV-2) infection in two clinics for sexually transmitted diseases in Santiago, Chile. Revista Medica de Chile, 133(3), 302–306.
Mbopi-Kéou, F.-X., Grésenguet, G., Mayaud, P., Weiss, H., Gopal, R., Matta, M., Paul, J. L., Brown, D. W., Hayes, R. J., Mabey, D. C. W., & Bélec, L. (2000). Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. The Journal of Infectious Diseases, 182(4), 1090–1096.
Mitchell, J., Lee, J., Woodyatt, C. R., Bauermeister, J., Sullivan, P., & Stephenson, R. (2017). Decisions About Testing for HIV While in a Relationship. Archives of Sexual Behavior, 46, 1069–1077.
Moriconi, N., Gabini, S., & Blajos, A. (2024). Strategies and challenges of self-care in sexual health: STI prevention and access to comprehensive sexuality education. Health Leadership and Quality of Life.
Nagot, N., Ouedraogo, A., Defer, M. C., Vallo, R., Mayaud, P., & Van de Perre, P. (2007). Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sexually transmitted infections, 83(5), 365–368.
Patel, R. (2004). Antiviral agents for the prevention of the sexual transmission of herpes simplex in discordant couples. Current Opinion in Infectious Diseases, 17(1), 45–48.
Perez, J., Lewis, K. A., Vargas, S., Klausner, J. D., & Konda, K. (2023). Does genital herpes symptom history predict herpes simplex virus type 2 antibody positivity? International Journal of STD & AIDS.
Perez, K., Bassett, D., Schembri, G., & Lee, V. (2012). STI screening in people living with HIV: are we getting the whole story? Journal of the International AIDS Society.
Petca, A., et al. (2020). Non-sexual HPV transmission and role of vaccination for a better future (Review). Experimental and Therapeutic Medicine, 20(6), 186.
Qiao, S., Li, X., Zhou, Y., Shen, Z., & Tang, Z. (2016). Interpersonal factors associated with HIV partner disclosure. AIDS Care, 28(Suppl 1), 37–43.
Roett M. A. (2020). Genital Ulcers: Differential Diagnosis and Management. American family physician, 101(6), 355–361.
Sen, P., & Barton, S. (2007). Genital herpes and its management. BMJ, 334, 1048–1052.
Suehiro, T. T., Gimenes, F., Souza, R., et al. (2021). High molecular prevalence of HPV and other sexually transmitted infections in a population of asymptomatic women. Revista do Instituto de Medicina Tropical de São Paulo, 63.
Thiyagarajan, S. (2022). Seroprevalence Pattern of Herpes Simplex Viruses (HSV-1 & 2) among STI Vulnerable Women Population. International STD Research & Reviews.
Wald, A., Langenberg, A., Link, K., Izu, A., Ashley, R., & Corey, L. (2001). Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA, 285(24), 3100–3106.
Wasserheit J. N. (1992). Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually transmitted diseases, 19(2), 61–77.
Wellings, K., Nanchahal, K., Macdowall, W., McManus, S., Erens, B., Mercer, C. H., Johnson, A. M., Copas, A. J., Korovessis, C., Fenton, K. A., & Field, J. (2001). Sexual behaviour in Britain: early heterosexual experience. Lancet (London, England), 358(9296), 1843–1850.
Wolf, J., et al. (2024). Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Reviews in Medical Virology, 34.
Workowski, K. A., & Bachmann, L. H. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187.
Wray, T. B., Chan, P. A., Simpanen, E. M., & Operario, D. (2018). A pilot, randomized controlled trial of HIV self-testing and real-time post-test counseling/referral on screening and preventative care among men who have sex with men. AIDS Patient Care and STDs, 32(9), 360–367.
Yüksel, M. Y., & Deniz, F. E. (2024). HPV Vaccines. Ağrı Tıp Fakültesi Dergisi.
Zayats, R., Murooka, T., & McKinnon, L. (2022). HPV and the Risk of HIV Acquisition in Women. Frontiers in Cellular and Infection Microbiology, 12.
Zereu, M., et al. (2006). Herpes simplex virus 2 (HSV-2) is not a co-factor of human papillomavirus (HPV) in adenocarcinoma of the uterine cervix. Journal of Clinical Oncology, 24(18_suppl), 5048.
Zuñiga, M. L., Blanco, E., Sanchez, L. M., Carroll, S., & Olshefsky, A. M. (2009). Preventing HIV and other STIs and reducing HIV-stigmatizing attitudes in high-risk youth. Vulnerable Children and Youth Studies, 4, 333–345.
